RxDoctor Payments Data

Gautham Gondi, MD

Sports Medicine · West Columbia, SCNPI 1952336034

Payments from drug & device makers

What this record shows

The money is spread across several categories — food and beverage (55.2%), speaking fees and gifts — rather than concentrated in one kind of arrangement. 16 manufacturers reported payments, led by Conformis, Inc. at 35.3% of the total. Reporting peaked in 2020 at $3,503 and has fallen 63.8% since, to $1,267 in 2025.

$8,425in general payments, 2019–2025

Across 60 payments — averaging $140.42 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Conformis, Inc.$3K
  • Zimmer Biomet$1K
  • Medacta USA, Inc.$1K
  • Johnson & Johnson$1K
  • Encore Medical, LP$893
  • Smith+Nephew$334
  • plus $823 from 10 others
$4,429in research payments, 2019–2025

Across 3 payments — averaging $1476.47 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Aesculap Biologics, LLC$4K

What the payments were for

  • Speaking & faculty fees$2,55530%
  • Travel & lodging$4686%
  • Food & beverage$4,65255%
  • Gifts$7509%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$8,425 in reported general payments places this provider in the 70th percentile of 158 sports medicine providers in South Carolina.

See all sports medicine providers in South Carolina

Medicare billing

Part B allowed, 2024
$328,702
Medicare patients
763
Services billed
4,173

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Celecoxib223$9,241
Diclofenac Sodium131$5,732
Tizanidine Hcl66$872
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen76$705
Methylprednisolone41$315
Tramadol Hcl45$203
Meloxicam35$84
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen16$75
Ondansetron Hcl29$72
Tranexamic Acid11$55
Amoxicillin37$54

Paid to pharmacies, not to this prescriber.

Other sports medicine in West Columbia

See the full list for South Carolina

Where these figures come from

Is this you, or does something look wrong? →